¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other primary disorders of muscles"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
  • primary sensation
    ÀÏÂ÷°¨°¢
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary sequestrum
    ÀÏÂ÷ºÎ°ñ, ¿ÏÀüºÐ¸®Á×Àº»À
  • primary sex character
    ÀÏÂ÷¼ºÂ¡
  • primary sex ratio
    ÀÏÂ÷¼ººñ
  • primary sterility
    ¿ø¹ßºÒÀÓ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • primary tooth
    ÀÏÂ÷Ä¡¾Æ
  • primary transcript
    ÀÏÂ÷Àü»ç¹°
  • primary tuberculosis
    ¿ø¹ß°áÇÙ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ¿ø¹ß¹è¸·¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary sterility
    ¿ø¹ßºÒÀÓ(Áõ)
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • primary symptom
    ÀÏÂ÷Áõ»ó
  • primary tooth
    (¢¡deciduous tooth) Á¥´Ï, Å»¶ôÄ¡¾Æ
  • primary immune response
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • primary lateral sclerosis
    ¿ø¹ß°¡ÂʰæÈ­Áõ
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
  • primary sex ratio
    ÀÏÂ÷¼ººñ
  • primary signalling system
    ÀÏÂ÷½Åȣü°è
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • primary antibody response
    ÀÏÂ÷Ç×ü¹ÝÀÀ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary battery
    ÀÏÂ÷ÀüÁö(ìéó­ï³ò®).
  • primary battery
    ÀÏÂ÷ÀüÁö(ìéó­ï³ò®)
  • primary biliary cirrhosis
    ¿ø¹ß¼º ´ãÁó¼º °£°æº¯(Áõ)
  • primary biliary cirrhosis
    ¿ø¹ß(¼º) ´ãÁó¼º °£°æº¯(Áõ)(ê«Û¡(àõ) ÓÅñðàõ ÊÜÌãܨ(ñø))
  • primary biological productivity
    ÀÏÂ÷»ý¹°»ý»ê·Â(¡­ßæÚªßæß§æ³).
  • primary bone
    ÀÏÂ÷»À
  • primary bone development
    ÀÏÂ÷»À¹ß»ý
  • primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷(¡­Òàøà).
  • primary bronchogenic carcinoma
    ¿ø¹ß(¼º)±â°üÁö¾Ï
  • primary bronchus
    ÀÏÂ÷±â°üÁö
  • primary bud
    ÀÏÂ÷½Ï
  • primary cancer
    ¿ø¹ß¾Ï(ê«Û¡äß)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • stress-related disorders
    ½ºÆ®·¹½º °ü·ÃÀå¾Ö(º´).
  • sweating disorders
    ¹ßÇÑÀå¾Ö(Û¡ùÒî¡äô)
  • temperature-dependent skin disorders
    ¿ÂµµÀÇÁ¸ ÇǺκ´
  • tobacco-related disorders
    Åä¹ÙÄÚ(´ã¹è)°ü·ÃÀå¾Ö(~º´).
  • topographic localization disorders
  • voice disorders, organic
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • voice disorders, psychogenic
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • abdominal muscles
    ¹è±ÙÀ°
  • arrector pili muscles
    Åм¼¿ò±Ù
  • auricular muscles
    ±Ó¹ÙÄû±ÙÀ°
  • dilator muscles
    È®´ë±Ù, È®Àå±Ù(üªíåÐÉ), »ê´ë±Ù(ߤÓÞÐÉ).
  • external intercostal muscles
    ¹Ù±ù´Á°ñ»çÀ̱Ù, ¿Ü´Á°£±Ù(èâ×ÎÊàÐÉ).
  • extraocular muscles
    ¿Ü¾È±Ù(èâäÑÐÉ).
  • extrinsic laryngeal muscles
    ¿ÜÈĵαÙ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
  • Primary amnion
    ÀÏÂ÷¾ç¸·
    [¿¾ ¿ë¾î] ÀÏÂ÷¾ç¸·
  • Primary villus
    ÀÏÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÏÂ÷À¶¸ð
  • Primary pregnancy
    ÀÏÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÏÂ÷ÀÓ½Å
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷Á¤¸ð¼¼Æ÷
  • Primary spermatocyte
    ÀÏÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÏÁ¤¸ð¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
HIVD Herniation(Herniated) of Inter-Vertebral Disc
  - Cervical HIVD
   &...
PEEP Positive End-Expiratory Pressure
  ? Ix
    1. PaO2 < 60 mmHg, ...
AL absolute latency; acinar lumen; acute leukemia; adaptation level; albumin; alcoholism [and other dru...
AMSAODD American Medical Society on Alcoholism and Other Drug Dependencies
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ICSD International Classification of Sleep Disorders
IDD Iodine Deficiency Disorders
LBD Low-back disorders
NINDS National Institute of Neurological Disorders and Stroke
NMD Neuronal migration disorders
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • primary hypophosphatemia

    primary immune response (ÀÏÂ÷ ¸é¿ª ¹ÝÀÀ

  • primary inclusion
    ÀÏÂ÷ ºÀÀÔü
  • primary infection
    ¿ø¹ß¼º °¨¿°, ÀÏÂ÷ °¨¿°
  • primary insanity
    ¿ø¹ß Á¤½Åº´, ¿ø¹ß¼º Á¤½Åº´
  • primary ionization
    ÀÏÂ÷ ÀÌ¿ÂÈ­
  • primary lateral sclerosis
    ¿ø¹ß¼º Ãø»ö °æÈ­Áõ
  • primary lobule
    ÀÏÂ÷ ¼Ò¿±
  • primary luetic lesion
    1±â ¸Åµ¶ º´¼Ò
  • primary muscle
    ÁÖµÈ ±ÙÀ°
  • primary neuron
    ÀÏÂ÷ ´º¿ì·Ð
  • primary non-inflammatory, myogenous pain disorder
    ¿ø¹ß¼ºÀÇ ºñ¿°Áõ¼º ±ÙÀ° µ¿Åë Àå¾Ö
  • primary ossification center
    ÀÏÂ÷ °ñÈ­ Áß½É
  • primary osteogenic irruption
    ÀÏÂ÷ »À ¹ß»ý ÁøÀÔ
  • primary pain
    ¿ø¹ß¼º µ¿Åë, ¿ø¹ß¼º ÅëÁõ
    Ä§ÇØ¼ö¿ë¼º ÀÔ·ÂÀ» À¯¹ßÇÏ´Â ÁøÂ¥ ±Ù¿ø¿¡ À§Ä¡ÇÏ´Â ÅëÁõ.
  • primary process
    ÀÏÂ÷ °úÁ¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
speech disorders Long-term disorders in speaking or in perception of speech.
(12 Dec 1998)
necrobiotic disorders A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis.
(12 Dec 1998)
neurotic disorders Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
(12 Dec 1998)
stress disorders, posttraumatic Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
delirium, dementia, amnestic, cognitive disorders Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
(12 Dec 1998)
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
dissociative disorders Sudden temporary alterations in the normally integrative functions of consciousness.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
immunoproliferative disorders Disorders characterised by abnormal proliferation of primary cells of the immune system or by excessive production of immunoglobulins.
(12 Dec 1998)
impulse control disorders Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
(12 Dec 1998)
infant nutrition disorders Malnutrition, occurring in infants ages 1 month to 24 months, which is due to insufficient intake of food, dietary nutrients, or a pathophysiologic condition which prevents the absorption and utilization of food. Growth and development are markedly affected.
(12 Dec 1998)
iron metabolism disorders Disorders in the processing of iron in the body: its absorption, transport, storage, and utilization.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á